Log In
Print this Print this

InsightDx Mammostrat test

  Manage Alerts
Collapse Summary General Information
Company General Electric Co.
DescriptionBreast cancer prognostic test that uses 5 immunohistochemical biomarkers to classify patients into high-, moderate- or low-risk categories for disease recurrence
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today